Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 842 of 6351
-
Engineered immune cells take on childhood cancers in first human trial
Disease control By invitation onlyThis is a first in human dose escalation trial to determine the safety of administering GPC2 CAR T cells in patients with advanced neuroblastoma or retinoblastoma.
Phase 1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Ear cartilage to the rescue? a tiny biopsy could rebuild knees
Disease control OngoingThe goal of this clinical trial is to learn if a single injection of autologous cartilage micrografts suspension, obtained through processing with a specialized technology patient's own small piece of ear cartilage, can improve knee osteoarthritis in adult men and women aged 18-7…
Sponsor: Regenera Activa Worldwide S.L. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New immunotherapy combo aims to stop relapse in young blood cancer patients
Disease control Recruiting nowA Phase I trial to determine the safety of targeted immunotherapy with daratumumab (DARA) IV after total body irradiation (TBI)-based myeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT) for children, adolescents, and young adults (CAYA) with high ri…
Phase 1 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a Two-Drug combo tame a rare and aggressive gynecologic cancer?
Disease control CompletedThe EPOCH study population is patients with tubo-ovarian carcinosarcoma or uterine carcinosarcoma with evidence of recurrence or progression. The study aims to determine the activity of eribulin as a single agent and the combination of eribulin and pembrolizumab as measured by c…
Phase 2 • Sponsor: Australia New Zealand Gynaecological Oncology Group • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can job frustration raise your blood pressure? a new study aims to find out
Knowledge-focused Recruiting nowBackground: Mental health is a national priority in France, especially in the workplace. The impact of poor quality of life at work on mental health has been demonstrated. Raising awareness of the importance of prevention within companies and the influence of working conditions s…
Sponsor: University of Burgundy • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Mind over paralysis: Brain-Controlled implant aims to move arms again
Disease control Recruiting nowCervical spinal cord stimulation can elicit arm and hand movements through recruitment of proprioceptive neurons in the dorsal roots. In participants with cervical spinal cord injury, the spare roots bellow the lesion can be used to reactivate motor function. Decoding of motor in…
Sponsor: Ecole Polytechnique Fédérale de Lausanne • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New heart valve device tested in humans for first time
Disease control Recruiting nowThe main objective of this study is to evaluate the feasibility and safety of the GEMINUS system in patients with severe symptomatic aortic stenosis. This is a prospective, open label, multicentre, single arm, first in human clinical study. Clinical follow up for all patients w…
Sponsor: Valve Medical • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug hopes to ease rare muscle diseases
Disease control Recruiting nowThe purpose of the study is to understand how the study medicine PF-06823859 (dazukibart) works in people with idiopathic inflammatory myopathies (DM and PM). These disorders cause inflammation that weakens the muscles that are important for movement and may also cause skin rash …
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo attack: immunotherapy plus chemo before surgery for head and neck cancer
Disease control Recruiting nowThis research study is evaluating effectiveness and safety of a combination of immunotherapy drug, pembrolizumab, with chemotherapy, as a possible treatment before and after surgery for squamous cell carcinoma of the head and neck (HNSCC). The combination of pembrolizumab and che…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a pill shield the brain and kidneys during heart surgery?
Disease control Recruiting nowThe goal of this mechanistic clinical trial is to learn about the effects of medications called soluble guanylyl cyclase stimulators on vascular function and markers of kidney and brain injury in patients having heart surgery. The main questions it aims to answer are: 1. Does so…
Phase 4 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New pill shows promise for advanced breast cancer in early trial
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of elacestrant over the course of 6 months in patients with estrogen receptor positive (ER+)/human epidermal growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-d…
Phase 2 • Sponsor: Stemline Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could some breast cancer patients skip radiation? major trial seeks answers
Disease control OngoingThis Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who …
Phase 3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can a single gene therapy calm Parkinson's for years?
Disease control OngoingThe objective of this study is to evaluate the long-term safety of AAV-GAD delivered bilaterally to the subthalamic nuclei (STN) in participants with Parkinson's disease.
Phase 1/2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a simple pill make CAR-T therapy work better for lymphoma?
Disease control Recruiting nowThe purpose of the study is to assess the safety and efficacy of once daily itacitinib oral administration in participants with diffuse large B-cell lymphoma (DLBCL) who will receive CAR-T cell therapy with axicabtagene ciloleucel (axi-cel).
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can an arthritis drug help clear HIV from the brain?
Disease control Recruiting nowThere is still no cure for the human immunodeficiency virus (HIV). While combination antiretroviral therapy (cART) is effective in decreasing deaths from HIV, infected individuals face a lifetime of treatment and many potential complications including end organ diseases such as H…
Phase 2 • Sponsor: William Tyor • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could heat pulses in the airways quiet a Smoker's cough?
Symptom relief CompletedThis is a prospective, multicenter, single arm and open-label clinical trial to evaluate the performance, effectiveness and safety of RheOx™ system in the treatment of the symptoms of chronic bronchitis in adult moderate to severe COPD patients.
Sponsor: Energenx Medical LTD. • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Gene therapy shot aims to save sight in batten disease kids
Disease control Recruiting nowThis is a first-in-human, open-label, single ascending dose study of TTX-381 for the treatment of ocular manifestations of CLN2 (Batten disease).
Phase 1/2 • Sponsor: Tern Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Brain-Sparing radiation may shield young minds from treatment side effects
Knowledge-focused Recruiting nowThe goal of this trial is to determine whether it is possible to minimize radiation dose to parts of the brain that are important for thinking and learning in children who require radiation to treat their tumor, and if this will help reduce neurocognitive (thinking and learning) …
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
DNA-Guided chemo aims to stop colon cancer return
Disease control PausedThe aims of this study are to evaluate if an intensified adjuvant treatment with FOLFOXIRI could increase the rate of cases with undetectable ct-DNA after chemotherapy and to evaluate if a further adjuvant treatment with Trifluridine/Tipiracil could increase the rate of cases wit…
Phase 2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Stroke survivors get new hope: major trial tests colchicine and ticagrelor to prevent repeat attacks.
Disease control Recruiting nowREDUCING INFLAMMATION IN ISCHEMIC STROKE WITH COLCHICINE, AND TICAGRELOR IN HIGH-RISK PATIENTS-EXTENDED TREATMENT IN ISCHEMIC STROKE.
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 15:10 UTC